959 related articles for article (PubMed ID: 33161896)
1. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
3. Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome.
Zhang L; Wang H; Ma Q; Liu Y; Chen A; Lu J; Ren L
Hormones (Athens); 2023 Jun; 22(2):263-271. PubMed ID: 36790635
[TBL] [Abstract][Full Text] [Related]
4. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study.
Tohidi M; Baghbani-Oskouei A; Ahanchi NS; Azizi F; Hadaegh F
Acta Diabetol; 2018 Oct; 55(10):1067-1074. PubMed ID: 30066042
[TBL] [Abstract][Full Text] [Related]
5. Triglycerides/high-density lipoprotein cholesterol is a predictor similar to the triglyceride-glucose index for the diagnosis of metabolic syndrome using International Diabetes Federation criteria of insulin resistance in obese adolescents: a cross-sectional study.
Aslan Çin NN; Yardımcı H; Koç N; Uçaktürk SA; Akçil Ok M
J Pediatr Endocrinol Metab; 2020 May; 33(6):777-784. PubMed ID: 32447329
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Triglyceride Glucose Index and Homeostasis Model of Insulin Resistance in Patients with Polycystic Ovary Syndrome.
Zheng Y; Yin G; Chen F; Lin L; Chen Y
Int J Womens Health; 2022; 14():1821-1829. PubMed ID: 36582617
[TBL] [Abstract][Full Text] [Related]
7. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome.
Blum MR; Popat RA; Nagy A; Cataldo NA; McLaughlin TL
J Endocrinol Invest; 2021 Oct; 44(10):2123-2130. PubMed ID: 33687700
[TBL] [Abstract][Full Text] [Related]
8. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
9. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of β cell function in a Chinese population with different glucose tolerance status.
Zhou M; Zhu L; Cui X; Feng L; Zhao X; He S; Ping F; Li W; Li Y
Lipids Health Dis; 2016 Jun; 15():104. PubMed ID: 27267043
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals.
Er LK; Wu S; Chou HH; Hsu LA; Teng MS; Sun YC; Ko YL
PLoS One; 2016; 11(3):e0149731. PubMed ID: 26930652
[TBL] [Abstract][Full Text] [Related]
11. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.
Hong Y; Yang D; Liu W; Zhao X; Chen X; Li L
J Biol Regul Homeost Agents; 2011; 25(3):365-74. PubMed ID: 22023761
[TBL] [Abstract][Full Text] [Related]
13. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
14. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
[TBL] [Abstract][Full Text] [Related]
15. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride/glucose index is a reliable alternative marker for insulin resistance in South American overweight and obese children and adolescents.
Locateli JC; Lopes WA; Simões CF; de Oliveira GH; Oltramari K; Bim RH; de Souza Mendes VH; Remor JM; Lopera CA; Nardo Junior N
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1163-1170. PubMed ID: 31472061
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.
Du T; Yuan G; Zhang M; Zhou X; Sun X; Yu X
Cardiovasc Diabetol; 2014 Oct; 13():146. PubMed ID: 25326814
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the Triglycerides to High-Density Lipoprotein Cholesterol ratio (TG/HDL-C) in prediction of metabolic syndrome in Polish obese children and adolescents.
Krawczyk M; Rumińska M; Witkowska-Sędek E; Majcher A; Pyrżak B
Acta Biochim Pol; 2018 Nov; 65(4):605-611. PubMed ID: 30451245
[TBL] [Abstract][Full Text] [Related]
19. Triglyceride is a useful surrogate marker for insulin resistance in Korean women with polycystic ovary syndrome.
Park SY; Cho YJ; Lee SR; Chung H; Jeong K
Yonsei Med J; 2015 May; 56(3):785-92. PubMed ID: 25837186
[TBL] [Abstract][Full Text] [Related]
20. Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.
Ebrahimi-Mamaghani M; Saghafi-Asl M; Pirouzpanah S; Aliasgharzadeh A; Aliashrafi S; Rezayi N; Mehrzad-Sadaghiani M
J Health Popul Nutr; 2015 Mar; 33(1):157-67. PubMed ID: 25995732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
